NM_000855.3:c.1991+9655A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_000855.3(GUCY1A2):c.1991+9655A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.079 in 151,942 control chromosomes in the GnomAD database, including 788 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.079 ( 788 hom., cov: 32)
Consequence
GUCY1A2
NM_000855.3 intron
NM_000855.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.940
Publications
1 publications found
Genes affected
GUCY1A2 (HGNC:4684): (guanylate cyclase 1 soluble subunit alpha 2) Soluble guanylate cyclases are heterodimeric proteins that catalyze the conversion of GTP to 3',5'-cyclic GMP and pyrophosphate. The protein encoded by this gene is an alpha subunit of this complex and it interacts with a beta subunit to form the guanylate cyclase enzyme, which is activated by nitric oxide. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.155 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GUCY1A2 | ENST00000526355.7 | c.1991+9655A>G | intron_variant | Intron 7 of 7 | 1 | NM_000855.3 | ENSP00000431245.2 | |||
| GUCY1A2 | ENST00000282249.6 | c.2084+9655A>G | intron_variant | Intron 8 of 8 | 1 | ENSP00000282249.2 | ||||
| GUCY1A2 | ENST00000347596.2 | c.2054+9655A>G | intron_variant | Intron 8 of 8 | 1 | ENSP00000344874.2 |
Frequencies
GnomAD3 genomes AF: 0.0790 AC: 11993AN: 151828Hom.: 784 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11993
AN:
151828
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0790 AC: 12004AN: 151942Hom.: 788 Cov.: 32 AF XY: 0.0794 AC XY: 5897AN XY: 74266 show subpopulations
GnomAD4 genome
AF:
AC:
12004
AN:
151942
Hom.:
Cov.:
32
AF XY:
AC XY:
5897
AN XY:
74266
show subpopulations
African (AFR)
AF:
AC:
6563
AN:
41516
American (AMR)
AF:
AC:
2212
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
95
AN:
3466
East Asian (EAS)
AF:
AC:
393
AN:
5186
South Asian (SAS)
AF:
AC:
117
AN:
4778
European-Finnish (FIN)
AF:
AC:
467
AN:
10590
Middle Eastern (MID)
AF:
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1962
AN:
67820
Other (OTH)
AF:
AC:
183
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
538
1075
1613
2150
2688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
218
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.